AstraZeneca AZN and partner Daiichi Sankyo announced that the European Commission has approved the expanded use of Enhertu ...

Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease who are eligible to receive the drug.

Evidence for chemotherapy-induced cognitive changes comes from studies that have used neuropsychological testing, imaging (structural and functional magnetic resonance imaging (MRI) and positron ...

Kisqali is not chemotherapy. It belongs to a group of drugs called kinase inhibitors. It’s a type of targeted therapy for breast cancer. Kisqali belongs to a group of drugs called kinase inhibitors.

The FDA approved several therapies in oncology in the month of March 2025. These drugs included treatments for ...

Chemotherapy can alter the immune system in ways that cause rashes and other skin changes. The drugs can also trigger skin changes directly. Severe rashes can cause painful, intense itching.

Researchers developed a manufacturing technique that rapidly generates large quantities of nanoparticles coated with drug-delivering polymers, which hold great potential for treating cancer. The ...

Chemotherapy is often given intravenously, meaning that the chemotherapy drugs are able to enter your bloodstream directly. While this sounds straightforward, there are a few ways that this can be ...

The EU approved AstraZeneca's Enhertu for certain breast cancer patients and Imfinzi for resectable NSCLC, showing ...

Throat cancer can cover an umbrella of different diseases and affect the vocal cords, sometimes permanently changing a person's voice as in Kilmer's case. The actor permanently lost his voice after ...